Axcella Health Inc.
AXLA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $57 | $43 | $37 | $42 |
| G&A Expenses | $16 | $19 | $17 | $16 |
| SG&A Expenses | $16 | $19 | $17 | $16 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $73 | $62 | $54 | $57 |
| Operating Income | -$73 | -$62 | -$54 | -$57 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$8 | -$3 | -$3 | -$2 |
| Pre-Tax Income | -$81 | -$65 | -$57 | -$59 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$81 | -$67 | -$59 | -$60 |
| % Margin | – | – | – | – |
| EPS | -1.27 | -1.76 | -1.85 | -3.61 |
| % Growth | 27.8% | 4.9% | 48.8% | – |
| EPS Diluted | -1.27 | -1.76 | -1.85 | -3.61 |
| Weighted Avg Shares Out | 64 | 38 | 32 | 17 |
| Weighted Avg Shares Out Dil | 64 | 38 | 32 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $2 |
| Interest Expense | $3 | $3 | $3 | $3 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$78 | -$61 | -$53 | -$56 |
| % Margin | – | – | – | – |